Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01897103 · ClinicalTrials.gov registry record
Platelet Activity in Vascular Surgery for Thrombosis and Bleeding
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 200
- Enrollment target
NCT01897103: Completed study, sponsored by NYU Langone Health.
NCT01897103 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01897103 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The proposed PIVOTAL study will examine a panel of platelet/coagulation activity markers during the perioperative period. The goal is to develop a clinically useful assessment of platelet/coagulation activity for risk stratification that may ultimately serve as a target for therapeutic intervention. This study will enroll 200 patients with peripheral artery disease undergoing vascular surgery. PIVOTAL is funded by American Heart Association and is scheduled to begin enrollment in July 2013 for approximately two years.
Primary Outcome
The main outcome measures are platelet activity, coagulation markers, platelet mapping and profiling.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2013-06 |
| Est. Completion | 2017-12 |
What the finished NCT01897103 record still lists
NCT01897103 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01897103 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01897103 about?
NCT01897103 is a clinical study titled "Platelet Activity in Vascular Surgery for Thrombosis and Bleeding". The proposed PIVOTAL study will examine a panel of platelet/coagulation activity markers during the perioperative period. The goal is to develop a clinically useful assessment of platelet/coagulation activity for risk stratification that may ultimately serve as a target for therapeutic intervention....
What is the current status of trial NCT01897103?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2013-06. Estimated completion is 2017-12.
Who is sponsoring clinical trial NCT01897103?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia